Coronavirus (COVID-19) Information and Resources

Information on the impact of coronavirus (COVID-19) on patient care and School/University operations. Plus, resources for the Penn Dental Medicine community and alumni.

ChiderChen

Chider Chen, PhD

Assistant Professor

Department of Oral and Maxillofacial Surgery / Pharmacology

544 Levy Building

Phone: 215-573-7848

Email: chenc10@upenn.edu

Professional Biography

Dr. Chen’s research focuses on stem cell biology and stem cell-based therapy for craniofacial and immune-related diseases, in which several novel physiological mechanisms have been identified. These findings have been translated into several pilot clinical studies to treat human patients with autoimmune diseases such as Systemic Lupus Erythematosus and Systemic Sclerosis; however, the reasons behind this stem cell-based therapy are not fully understood. As a secretome, mesenchymal stem cells (MSCs) release large amounts of cytokines and small vesicles for immunoregulation and communication with surrounding cells. The major goal of Dr. Chen’s current studies is to investigate how small vesicles are controlled by a set of membrane traffic proteins for cell component reuse in stem cell transplantation.

Dr. Chen is also interested in bone biology and dissects the role of MSCs in bone/marrow homeostasis. He focuses on aging which leads a deterioration of the physiological systems and is a paradigmatic example of homeostasis collapse. Changes in histone modifications have been linked to stabilizing nuclear F-actin scaffold and actomyosin contractility, suggesting that nuclear size and shape may be regulated by specific histone signatures. The major goal of these studies is to investigate how MSCs participate in rejuvenation of senescent cells via histone modifications.

Recently, Dr. Chen is involved in oral cancer research to identify the physiological roles of cancer stem cells, stromal populations, and immune components in tumor microenvironment through single cell transcriptomic analysis. Upon successful determination of oral cancer biomarkers, the capacities of diagnosis, treatment, and tumor margin identification will be largely improved in head and neck cancer. Dr. Chen’s research is currently supported by the NIH/NIDCR.

HONORS / CREDENTIALS
  • NIDCR Small Grant Program for New Investigators, 2019-2021
  • Member, PDM Summer Retreat Organizing Committee, University of Pennsylvania, 2019 – Present
  • Assistant Professor, tenure-track, Department of Oral & Maxillofacial Surgery and Pharmacology, University of Pennsylvania, School of Dental Medicine, 2018 – Present
  • Member, DScD Thesis Committee, University of Pennsylvania, 2018 – Present
  • Pathway to Independent Award K99/R00, National Institute of Dental and Craniofacial Research/National Institute of Health, 2016-2022
  • Ruth L. Kirschstein Rheumatology T32 Training Award, 2016
  • Scholar of California Institute for Regenerative Medicine (CIRM) Training Program, 2012-2014
  • Pre-doctoral Candidate Research Award, University of Southern California, Ostrow School of Dentistry, 2010-2013
  • Travel Award of the 8th Asia Pacific Symposium on Neural Regeneration in conjunction with the 5th Pan Pacific Symposium on Stem Cells and Cancer Research, 2012
  • Member, American Association for the Advancement of Science 2011 – Present
  • Member, International Association for Dental Research, 2009 – Present
  • Research Assistant, University of Southern California, Los Angeles, 2009 – 2014
  • Research Associate, BioPromed Biotech Co., Ltd., Taipei, 2003 – 2009
  • Research Associate, BioAgri Corp., Taipei, 1999 – 2003

View Dr. Chen’s CV »

Education
  • Post-Doctoral Fellow, Stem Cell Biology, University of Pennsylvania, Philadelphia, 2018
  • Post-Doctoral Fellow, Craniofacial Biology, University of Southern California, Los Angeles, 2014
  • Ph.D., Craniofacial Biology, University of Southern California, Los Angeles, 2014
Selected Publications

Find Articles On

Find Articles On PubMed Find Articles On Google Scholar